With a market cap of $51.3 billion, Nasdaq, Inc. (NDAQ) is a leading global technology company that powers capital markets and the broader financial ecosystem through advanced market infrastructure and innovative technology solutions. By delivering cutting-edge data, analytics, and intelligence, it enables organizations to seize opportunities, manage risk, and build resilient financial systems.
The New York-based company is set to announce its fiscal Q3 2026 results soon. Ahead of this event, analysts forecast NDAQ to report an adjusted EPS of $1.02, a rise of 15.9% from $0.88 in the year-ago quarter. It has exceeded Wall Street's earnings estimates in the last four quarters.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
For fiscal 2026, analysts expect Nasdaq to post an adjusted EPS of $4.15, up 19.3% from $3.48 in fiscal 2025.
www.barchart.com Shares of Nasdaq have risen 4% over the past 52 weeks, lagging behind both the S&P 500 Index's ($SPX) 14.4% gain. However, the stock has outpaced the State Street Financial Select Sector SPDR ETF's (XLF) marginal decline over the same period.
www.barchart.com Nasdaq reported Q2 2026 results on Jul. 23, with better-than-expected adjusted EPS of $1.07. This outperformance was driven by a 15% increase in total net revenue to $1.5 billion, led by a 19% jump to $621 million in its capital access platforms segment due to high-profile exchange listings like SpaceX's record-breaking IPO. Additionally, investor sentiment was supported by strong market-volatility trading volumes, a 16% growth in financial technology revenue to $539 million, and management reassuringly brushing off competitive threats from perpetual futures.
Analysts' consensus view on NDAQ stock is bullish, with a "Strong Buy" rating overall. Among 19 analysts covering the stock, 13 recommend "Strong Buy," three "Moderate Buys," and three suggest "Hold." The average analyst price target for Nasdaq is $110.28, suggesting a potential upside of 19.9% from current levels.
On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
This Healthcare Stock Just Raised Its Dividend by Nearly 15%. Eli Lilly vs. Novo: The Hidden Battle Behind the Weight-Loss Platform Reshaping Industries Micron Just Reported Earnings in the Middle of a Memory Shortage. Here Are the Numbers You Need to Know. This Analyst Just Downgraded Moderna Stock. Here's Why.